Desq Long
Sign in
SEC FORM 4
$0.00

BridgeBio Oncology Therapeutics, Inc. (BBOT)

Acquisition (code A) of 9,038 shares at $0 per share.

Reporting Person Cobo Marc · Officer Title Principal Accounting Officer · Transaction Code A

Traded Sep 10, 2026 · Disclosed Sep 14, 2026

Source: SEC Form 4 · 0001193125-26-390624 · filed 2026-09-14 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "BridgeBio Oncology Therapeutics, Inc. (BBOT)." Disclosed 2026-09-14. https://desqlong.com/cards/0001193125-26-390624-1 (retrieved 2026-09-26).